A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

11.4K views

DOI:

10.3791/56138

October 21st, 2017

In This Article

Summary

Here we describe a common method to induce chronic liver injury in mice by feeding of a choline-deficient and ethionine-supplemented (CDE) diet. We demonstrate health monitoring, liver perfusion, isolation, and preservation. A time course of six weeks can inform about liver injury, pathohistology, fibrosis, inflammatory, and liver progenitor cell responses.

Abstract

Chronic liver diseases, such as viral hepatitis, alcoholic liver disease, or non-alcoholic fatty liver disease, are characterized by continual inflammation, progressive destruction and regeneration of the hepatic parenchyma, liver progenitor cell proliferation, and fibrosis. The end-stage of every chronic liver disease is cirrhosis, a major risk factor for the development of hepatocellular carcinoma. To study processes regulating disease initiation, establishment, and progression, several animal models are used in laboratories. Here we describe a six-week time course of the choline-deficient and ethionine-supplemented (CDE) mouse model, which involves feeding six-week old male C57BL/6J mice with choline-deficient chow and 0.15% DL-ethionine-supplemented drinking water. Monitoring of animal health and a typical body weight loss curve are explained. The protocol demonstrates the gross examination of a CDE-treated liver and blood collection by cardiac puncture for subsequent serum analyses. Next, the liver perfusion technique and collection of different hepatic lobes for standard evaluations are shown, including liver histology assessments by hematoxylin and eosin or Sirius Red stainings, immunofluorescent detection of hepatic cell populations as well as transcriptome profiling of the liver microenvironment. This mouse model is suitable for studying inflammatory, fibrogenic, and liver progenitor cell dynamics induced through chronic liver disease and can be used to test potential therapeutic agents that may modulate these processes.

Introduction

The liver is the largest glandular metabolic organ of the body and has many complex functions. Key roles for the liver include digestion, metabolism, detoxification, storage of essential nutrients, production of blood plasma protein components, and immunity mediated through resident macrophages or Kupffer cells. The liver has a great ability to regenerate even if up to 70-90% of its total mass is lost. In the event of acute liver injury, such as seen following a partial hepatectomy or acetaminophen poisoning, the remaining healthy hepatocytes proliferate to repair the damage in a highly coordinated process1. However, when the hepatocytes are ch....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Animal Experimentation

All animal studies described in this investigation were approved by the Curtin University Animal Ethics Committee (Approval number: AEC_2014_28) prior to commencement of the experiments and performed in accordance with the Australian code for the care and use of animals.

  1. Animals
    1. Use six-week old male C57BL/6J mice for the experiments.
  2. Experimental design
    1. Following arrival at the Animal Facility, allow mice to acclimatize for four days prior to commencement of any experiments.
    2. House mice on wheaten chaff bedding,....

Access restricted. Please log in or start a trial to view this content.

Results

Throughout the six-week time course of CDE-induced chronic liver injury, parameters were assessed on days 7 (induction phase), 14 and 21 (establishment phase) and 42 (maintenance phase). Compared to control mice, CDE-treated mice lost up to 20% of their initial body weight in an initial adaptation phase and tend to regain weight in the establishment and maintenance phases (Figure 1). The body weight was inversely correlated with serum alanine.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Chronic liver disease is often a silent disease with most patients being asymptomatic and it is one of the major contributors to morbidity and mortality worldwide. Chronic alcoholism and hepatitis C virus infection are the leading causes. Chronic liver injury is characterized by hepatic inflammation, fibrosis and in severe cases cirrhosis, carcinoma and ultimately liver failure. There is currently no cure available and although major advances have been made to understand the mechanisms of liver disease, new therapeutic a.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

There is nothing to be disclosed by the authors.

Acknowledgements

This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (APP1042370, APP1061332, APP1087125). The authors would like to thank the Curtin Health Innovation Research Institute staff for technical assistance.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Six-week-old male C57BL/6J mice Animal Resource Centre of Western Australia, Murdoch, WA,  AustraliaN/A
10 Kg Steam Cut Wheaten Chaff Specialty Feeds, Glen Forrest, WA, Australia N/A
Water for irrigation 1000ml bottle (Baxter) Surgical House, Perth, WA, Australia AHF7114A
Choline- deficient diet, modified (pellets) MP Biomedicals Australasia Pty Limited, WA, Australia 02960210
DL-Ethionine Sigma-Aldrich, Castle Hill, NSW,  Australia E5139-25G
Ketamil injection Troy Laboratories Pty Limited, Glendenning, NSW, Australia N/A
Ilum Xylazil-20 injection Troy Laboratories Pty Limited, Glendenning, NSW, Australia N/A
27G x 1/2", Regular Wall Needle Terumo Australia Pty Limited, NSW, Australia NN-2713R
Syringes Terumo 1ml and 10ml Terumo Australia Pty Limited, Macquarie Park, NSW, Australia 1018242, 1018037
Tissue-Tek OCT compound VWR International Pty Limited, Tingalpa, QLD, Australia 25608-930
Neutral buffered formalin Amber Scientific, Midvale, WA, Australia NBF-2.5L
Ethanol absolute anaLaR normalpur VWR International Pty Limited, Tingalpa, QLD, Australia 20821.33
Superfrost Plus slides Grale Scientific Pty Limited, Ringwood, VIC, Australia SF41296SP
Dako Protein Block, serum-free Dako Australia Pty Limited, North Sydney, NSW, Australia  X090930-2
Dako antibody diluent Dako Australia Pty Limited, North Sydney, NSW, Australia  s0809
rat anti-CD45 eBioscience, San Diego, California, USA m0701 1/200 dilution
rabbit anti-panCK Dako Australia Pty Limited, North Sydney, NSW, Australia  Z06221/300 dilution
Goat anti-rabbit (Alexa Fluor 488)Life Technologies Australia Pty Limited, Mulgrave, VIC, AustraliaA-110081/500 dilution
Goat anti-rat IgG (Alexa Fluor 594) Life Technologies Australia Pty Limited, Mulgrave, VIC, Australia A-110071/500 dilution
ProLong Gold Antifade Reagent with DAPI Life Technologies Australia Pty Limited, Mulgrave, VIC, Australia P36935  
Picrosirius Red Stain KitPolysciences Inc., Warrington, PA, USA ab150681 

References

  1. Taub, R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 5, 836-847 (2004).
  2. Kohn-Gaone, J., Gogoi-Tiwari, J., Ramm, G. A., Olynyk, J. K., Tirnitz-Parker, J. E. The role of liver progenitor cells during liver regeneration....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Liver Perfusion TechniqueCardiac Puncture MethodHistology AssessmentSirius Red StainingImmunofluorescent DetectionTranscriptome ProfilingLiver Progenitor CellsHepatic Fibrosis